NCT05943457 - Vitamin K2 Supplementation in Adult Episodic Migraine | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

Migraine HeadacheArterial StiffnessVitamin K Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin K2 or menaquinone-7

Vitamin K2 (MK7) 360 mcg/day orally once daily for 6 months

OTHER

Placebo

Placebo pills will be administered orally once daily for 6 months

Trial Locations (1)

Lebanese American University Medical Center - Rizk Hospital, Beirut